1. Introduction {#sec1}
===============

Depression is one of the major mental health problems categorized under mood disorders and characterized by persistent experience of a depressed mood and loss of interest \[[@B1]\] and accompanied by symptoms like change in appetite, disrupted sleep patterns, increased or diminished activity level, impaired attention and concentration, and markedly decreased feelings of self-worth.

In severe forms, death wish or attempts to take one\'s life are present. Early diagnosis is essential, as in addition to the mental suffering, it causes significant social and occupational impairment \[[@B2]\]. HIV/AIDS is one of the global burden diseases, recognized as a serious public health problem and has spread throughout the world affecting all population \[[@B3]\].

It is a chronic and life-threatening illness and overwhelming to the individual \[[@B4]\]. Its life-threatening nature may induce fear of impending mortality. The medical squeal of HIV infection its associated opportunistic infections and side effects of antiretroviral treatment can mimic symptoms of depression (fatigue, concentration problems, somatic symptoms, decreased appetite, and weight loss \[[@B5]\]). When patients with HIV/AIDS develop depression, it accentuates the disease burden and is associated with poor health outcomes. It is also linked with poor antiretroviral therapy (ART) adherence resulting in loss of therapeutic effect, besides having a negative impact on the quality of life of people with HIV/AIDS. Unfortunately, depression is not diagnosed in majority of patients, and therefore, the condition goes untreated \[[@B6]\].

Reasons for high prevalence of depression among people living with HIV/AIDS (PLWHA) could be many \[[@B7]\]. Studies have revealed that depression is associated with different sociodemographic and health-related factors. It is persistently highly prevalent among the poor \[[@B8], [@B9]\]. Studies in Botswana and Uganda, for example, revealed that depression was associated with food insecurity and the sex of the persons infected with HIV/AIDS \[[@B8]--[@B10]\]. The study carried out in Tigray, North Ethiopia, revealed that it was associated with the place of residence, economic status, and occupational status \[[@B11]\]. Depression tends to weaken a person\'s capacity for judgment, thereby predisposing for risky behaviors \[[@B12]\]. Recent data on the topic is lacking in Jimma; therefore, this study is aimed at determining the prevalence of depression and associated factors among PLWHA who are in ART follow-up at JUMC, Jimma.

Research evidence on the magnitude of depression among PLWHA is important to design more effective treatment programs for the management and prevention of its consequences and to improve their quality of life.

This study will provide research evidence for stakeholders on the magnitude of depression among PLWHA, in order to implement clinical and community-based intervention programs for the management and prevention of depression among PLWHA, aimed at improving their quality of life.

2. Methods and Materials {#sec2}
========================

2.1. Study Area and Period {#sec2.1}
--------------------------

Jimma University Medical Center is found in Oromia region, southwest of Ethiopia in Jimma town, which is located 346 km to the southwest of Addis Ababa and provides health services for population in the town and the surrounding districts. In the town, there are different health facilities: four health centers, one general hospital and one specialized hospital currently, and one health center, and the two hospitals are giving ART service for people living with HIV/AIDS. In Jimma University Medical Center Hospital, there is a separate ART clinic at which care and follow-up are given for 3075 PLWHA. The study was conducted from April 3 till May 2018.

2.2. Study Design {#sec2.2}
-----------------

Institutional-based cross-sectional study design was used.

2.3. Source Population {#sec2.3}
----------------------

The source population were all PLWHA attending ART Clinic at Jimma University Medical Center.

2.4. Study Population {#sec2.4}
---------------------

The study population were all PLWHA attending ART clinic at JUMC and who were included in to the sample

2.5. Eligibility Criteria {#sec2.5}
-------------------------

### 2.5.1. Inclusion Criteria {#sec2.5.1}

Participants aged older than or equal to 18yearsParticipants who are on routine appointment receiving ART treatment

### 2.5.2. Exclusion Criteria {#sec2.5.2}

Bereavement within 3 monthsFemale patient in postpartum periodThose who have not done their CD4 count in six months preceding data collection

2.6. Sample Size Determination {#sec2.6}
------------------------------

The sample size was determined by using single population proportion formula. The following assumptions were made: marginal error (*d*) that was tolerated in either sides of the true proportion to be 5%, using 95% confidence level,*α* = 0.05, and the proportion of depression in HIV/AIDS patient taken from a research done in Fitche Zonal Hospital in 2017(*P*) = 76.7%. Those on steroid treatment \[[@B8]\] $$\begin{matrix}
{n = \frac{\left( {Z\left( {\alpha/2} \right)} \right)^{2}P\left( {1 - P} \right)}{d^{2}},} \\
{n = \frac{\left( 1.96 \right)^{2}.767\left( {1 - .767} \right)}{\left( .05 \right)^{2}} = 275,} \\
\end{matrix}$$where *n* is the required sample size/minimum sample size required for the study.

*Z* is the standard normal distribution (*Z* = 1.96) with confidence interval of 95%, and *α* = 0.05.

*P* is the prevalence/population proportion (*P* = 0.767).

*d* is the desired absolute precision, a tolerable margin of error (*d* = 0.05) formula with 10% nonresponse rate which is 28. Therefore, the final sample size is 303.

2.7. Sampling Technique and Sampling Procedures {#sec2.7}
-----------------------------------------------

Simple random sampling technique was used to select the study subjects.

First, the list of patients was obtained from the database and registration logbook. Then, the lottery method was used to select each study subject.

2.8. Data Collection Instrument and Procedure {#sec2.8}
---------------------------------------------

Data was collected using pretested interviewer-administered questionnaire, patient card review. Generally, questionnaire for this study contains 57 items and takes 30-45 minutes.

*Part I*. *Socioeconomic characteristics* were developed based on reviewed literature \[[@B8]\]. This contains 10 items with both open-ended and close-ended questions.

*Part II*. *Behavioral factors* are questions pertaining to substance use and sexual practices developed based on revied literature \[[@B41]\]. This contains 05 items with close-ended questions.

*Part III*. Clinical factors are from some of the questionnaires adapted from another literature \[[@B36]\]. This contains 10 items with both open- and close-ended questions and Morisky Medication Adherence Scale. Eight questionnaires were standard which contains 08 items with close-ended questions; adherence was defined as adherent (high) with a Morisky Medication Adherence Scale score of 0 and nonadherent (medium, low) with a score of 1 \[[@B44], [@B45]\]. The reliability of the instrument calculated using Cornbrash\'s alpha coefficient was 0.725.

*Part IV*. *Patient Health Questionnaire (PHQ-9) depressive symptom scale* contains 09 items. It was a Likert scale with the following response options:Pateint health questionnaire (PHQ-9) depressive symptom scale have 09 items. 0 = not at all, 1 = several days, 2 = more than half the days, and 3 = nearly every day. Classification of depression was measured by verbal responses of participants to PHQ-9 scale and expressed in scores. PHQ-9 was categorized as follows: severe depression: respondent with a score between 20 and 27; moderately severe depression: respondent with a score between 15 and 19; moderate depression: respondent with a score between 10 and 14; mild depression: respondent with a score between 5 and 9; minimal depression: respondent with a score between 1 and 4; and nondepressed respondent with score 0 \[[@B46], [@B47]\]. The internal consistency of this instrument using Cornbrash\'s alpha was 0.883.

*Part V*. *Psychosocial factors: Oslo Social Support Scale* contains 03 items by using close-ended questions. It was standard measured by verbal responses of participants to Oslo Social Support Scale and expressed in scores. Social support is categorized as follows: strong social support: respondent with a score between 12 and 14; moderate social support: respondent with a score between 9 and 11; and poor social support: respondent with a score between 3 and 8 \[[@B48]\]. The instrument showed reliability value 0.721, by Cornbrash\'s alpha.

*Perceived HIV related stigma* contains 12-item standard Likert scale with the following response options: 1 = strongly disagree, 2 = disagree, 3 = agree, and 4 = strongly agree. It contains personalized stigma, disclosure, public attitudes, and negative self-image. Perceived HIV-related stigma is assessed with a Likert scale\[[@B48]\]. The Cornbrash\'s alpha coefficient value was 0.648.

2.9. Data Processing and Analyses {#sec2.9}
---------------------------------

The data were analyzed by SPSS version 23, using simple descriptive statistics.

The presence of crude association between the dependent variable with each independent variable was determined by bivariate logistic regression analysis. Variables that showed statistically significant association by bivariate analysis (*p* \< 0.25) were further subjected to multivariable logistic regression analysis to control the confounding variables. The significance of association was determined at 95% confidence interval and *p* value \< 0.05.

2.10. Data Quality Management {#sec2.10}
-----------------------------

Two days of training were given to data collectors (four BSc nurses) and supervisors (two BSc nurses) on the objectives, clarity of tools, and overall data collection procedures to standardize interview procedures and reduce interviewers\' bias. The final version of the questionnaire was translated into the Afan Oromo and Amharic language and once again retranslated in English language by bilingual experts, to check for language consistency of the tool.

The questionnaires were pretested on 5% of the sample at Shenen Gibe Hospital to determine clarity of the tool and feasibility of the study. At the end of each day, during data collection period, the collected data were checked for consistence and completeness.

2.11. Ethical Consideration {#sec2.11}
---------------------------

The study was conducted after the investigator gets an approval letter from the Institutional Review Board of Jimma University. Permission letter was provided to the hospital administrator before data collection. The purpose and procedure of data collection were clearly stated for the participants, and confidentiality and privacy were ensured. The right to refuse or withdraw from the study was respected. There were no risks or hazards to the participants, and there was no incentive for the participants. Those participants found to have suicide attempt and severe depression were referred to the psychotic clinics for early treatment.

3. Results {#sec3}
==========

3.1. Socioeconomic Characteristics of the Participants {#sec3.1}
------------------------------------------------------

All the 303 patients who were selected for the study voluntarily responded to the interview, giving 100% response rate. More than half of the respondents, 159 (52.5%), were females. Maximum representation was by patients who were in the productive age group 25-44 yrs, 202 (66.7%) with mean age 39.36 (SD ± 9.63 years); they were married (125 (41.3%)) and lived with their families (217 (71.6%)). Most had primary education (127 (41.9%)) and were employed (100 (33%)). Urban residents constituted the majority (269 (88.8%)), and 203 (67%) were earning less than 1380 ETB per month. They were of Oromo ethnicity (145 (47.9%)), Orthodox Christians (121 (39.9%)) with moderate social support (143 (47.2%)) ([Table 1](#tab1){ref-type="table"}).

3.2. Prevalence of Depression {#sec3.2}
-----------------------------

Nearly one-third (94 (31%)) of the participants were found to have depression, while 72 (24%) had mild depression, 19 (6%) had moderate depression, and 3 (1%) were found to be with moderately severe depression ([Figure 1](#fig1){ref-type="fig"}).

3.3. Substance Use and Risky Behavior {#sec3.3}
-------------------------------------

Interview on the behavioral characteristics revealed that few numbers of the respondents (53 (17.5%)) used alcohol, 7 (2.3%) of the participants smoked tobacco, and 78 (25.7%) of the participants chewed khat. Information on the sexual practices showed that 25 (67.6%) reported inconsistent use of condom whereas 12 (32.4%) never used a condom ([Table 2](#tab2){ref-type="table"}).

3.4. Clinical Characteristics of the Participants {#sec3.4}
-------------------------------------------------

Most of the participants (290 (95.7%)) were at HIV stage T1, 125 (41.3%) had been diagnosed as HIV infected for the past 6-10 years, and 128 (42.2%) had been on treatment since the last 6-10 yrs.

While most participants (226 (74.6%)) had never been screened for depression prior to initiation of ART, 155 (51.2%) received treatment with 1e/Tdf-3tc-Nvp. Majority of the participants (264 (87.1%)) did not experience side effect from ART and 218 (71.9%) did not have opportunistic infection, 147 (48.5%) had recent CD4 cell count which was between 200 and 499 cells/mm^3^, and 228 (75.2%) of the participants had never received food supplement from ARV treatment programmer. But more than half of the respondents (164 (54.1%)) reported good adherence to ART ([Table 3](#tab3){ref-type="table"}).

3.5. Aspects of Stigma {#sec3.5}
----------------------

The HIV/AIDS-related stigma scale showed personal stigma mean score 6.23 SD ± 1.572, disclosure mean score 7.49 SD ± 1.819, public attitude mean score 5.78 SD ± 1.060, and self-image mean score 5.88 SD ± 1.386 ([Table 4](#tab4){ref-type="table"}).

3.6. Factors Associated with Depression among People Living with HIV/AIDS {#sec3.6}
-------------------------------------------------------------------------

Among all the explanatory variables subjected to bivariate binary logistic regression analysis, sex of participant, marital status, occupation, social support, medication adherence, alcohol drinking, khat chewing, opportunistic infection, and CD4 count had *p* value \< 0.25 and were further entered into multivariable analysis to control for confounding.

In multivariable logistic regression, four independent predictor variables (sex, marital status, opportunistic infection, and medication adherence) were found to be significantly associated with depression at *p* value less than 0.05.

Susceptibility for depression was more among HIV-infected females (AOR: 0.510, 95% CI: 0.264-0.986), widowed persons (AOR: 3.610, 95% CI: 1.649-7.901), contracting opportunistic infections (AOR: 3.122, 95% CI: 2.719-61.923), and poor medication adherence (AOR: 0.470, 95% CI: 0.266-0.831) ([Table 5](#tab5){ref-type="table"}).

4. Discussion {#sec4}
=============

This study was conducted to investigate the prevalence of depression among PLWHA enrolled in ART and its association with sociodemographic, behavioral, clinical, and social support factor.

4.1. The Prevalence of Depression {#sec4.1}
---------------------------------

This study revealed that the prevalence of depression among the study participants was 94 (31%) and was lower than that of the studies conducted in Ethiopia at Debre Birhan (38.94%) and in northern Showa (76.7%) \[[@B41], [@B8]\]. Studies done in India showed that the prevalence of depression was 58.75% and 67.3% at different periods \[[@B7], [@B32]\] similarly in Brazil, Denmark, and north central Nigeria (42.3%, 61%, and 56.7%, respectively) \[[@B29], [@B30], [@B33]\], but higher than the prevalence among patients at Hawassa, Ethiopia (24.5%) \[[@B49]\].

The variations could be attributed to differences in sample size, instruments used to determine depression, and different geographical locations. Moreover, it is likely that responding by a face-to-face interview may have prompted the participants to give socially desirable answers. However, this very significant finding in the current study highlights the need for early diagnosis of depression in this vulnerable population.

4.2. Factors Associated with Depression {#sec4.2}
---------------------------------------

Research shows gender is closely associated with depression with women being more prone to depression. This study confirmed that HIV-infected males were 49% less likely to develop depression when compared to females. Similar findings were shown in studies from northern Showa, north central Nigeria, Tehran, and Hawassa \[[@B8], [@B33], [@B37], [@B49]\]. Women in male-dominated societies are at the receiving end for all the misfortunes such as poverty, violence, discrimination, and single parenthood. Being diagnosed with HIV adds to this burden and makes them more vulnerable to depression than males. The findings are negated by the study at Harar region of Ethiopia \[[@B36]\].

This study found that the marital status of the HIV-infected person is a significant factor for comorbidity with depression. Widowhood predisposed a person nearly 4 times to develop depression when compared to those who had a stable marital life. The findings are in line with studies conducted in Harar and Hawassa (Ethiopia) \[[@B36], [@B37]\] and Tehran in Iran \[[@B49]\]. Unstable marital relationships and loss of partner predispose for depression, but presence of good social support can be a buffer against stress and depression.

Another major finding of this study was the risk for depression increased threefold when the person contracts opportunistic infections, which is in line with a study at Fiche, Ethiopia \[[@B8]\]. Opportunistic infections have synergistic effects on the disease progression and AIDS-related mortalities. Depression has an effect on immunosuppression, and immunosuppression inversely predisposes depression.

Good medication adherence can lower the risk for depression by more than half as revealed through this study and supported by similar studies in Addis Ababa, Ethiopia \[[@B42]\]. HIV-infected people often default on medication due to difficulty in accessing the health center, being forgetful and due to unpleasant side effects of antiretroviral therapy. This significant finding reemphasizes the need for creating awareness on medication compliance among HIV-infected people and providing supportive services for individuals on treatment.

It is perplexing that this study did not find a significant association between depression and social support, perceived stigma, substance use, and CD4 count among the respondents, contrary to available literature. The recent CD4 cell count of most participants in this study was between 200 and 499 cells/mm^3^. Moreover, the tendency to give socially desirable responses in an interview may be a reason for this contradiction.

Individual\'s sex, marital status, opportunistic infections, and medication adherence were factors associated with risk of developing depression among people living with HIV/AIDS.
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###### 

Distribution of study participants by their socioeconomic characteristics, Jimma University Medical Center, April to May 2018 (*N* = 303).

  Characteristics        *N*       \%
  ---------------------- --------- ------
  Sex                              
   Male                  144       47.5
   Female                159       52.5
   Total                 303       100
  Age                              
   18-24                 13        4.3
   25-44                 202       66.7
   45-64                 80        26.4
   \>65                  8         2.6
   Total                 303       100
  Marital status                   
   Married               125       41.3
   Single                42        13.9
   Divorced              74        24.4
   Separated             6         2.0
   Widowed               56        18.5
   Total                 303       100
  Living status                    
   With family           217       71.6
   Alone                 53        17.5
   With relatives        33        10.9
   Total                 303       100
  Educational status               
   No education          63        20.8
   Primary school        127       41.9
   Secondary school      42        13.8
   Above secondary       71        23.4
   Total                 **303**   100
  Occupation                       
   Farmer                18        5.9
   Government employee   100       33.0
   Student               12        4.0
   Daily laborer         91        30.0
   Housewife             68        22.4
   Unemployed            14        4.6
   Total                 303       100
  Residence                        
   Rural                 34        11.2
   Urban                 269       88.8
   Total                 303       100
  Monthly income                   
   \<1380                203       67.0
   1381-2872             45        14.9
   \>2872                55        18.2
   Total                 303       100
  Ethnicity                        
   Oromo                 145       47.9
   Amhara                82        27.1
   Tigre                 19        6.3
   Gurage                26        8.6
   Dawuro                31        10.2
   Total                 303       100
  Religion                         
   Muslim                105       34.7
   Orthodox              121       39.9
   Protestant            63        20.8
   Catholic              14        4.6
   Total                 303       100
  Social support                   
   Poor support          117       38.6
   Moderate support      143       47.2
   Good support          43        14.2
   Total                 303       100

###### 

Distribution of study participants by their behavioral characteristics, Jimma University Medical Center, April-May 2018 (*N* = 303).

  Characteristics            *N* = 303               
  -------------------------- ----------- ----- ----- ------
  Alcohol use                                        
   Yes                       28          25    53    17.5
   No                        116         134   250   82.5
  Tobacco use                                        
   Yes                       5           2     7     2.3
   No                        139         157   296   97.7
  Khat use                                           
   Yes                       44          34    78    25.7
   No                        100         125   225   74.3
  Unsafe sex practice                                
   Yes                       22          15    37    12.2
   No                        122         114   266   87.8
  Condom utilization                                 
   Inconsistent condom use   15          10    25    67.6
   Never use a condom        1           3     4     32.7

###### 

Distribution of study participants by their clinical characteristics, Jimma University Medical Center, April-May 2018 (*N* = 303).

  Characteristics                                         *N* (*n* = 303)   \%
  ------------------------------------------------------- ----------------- ------
  Side effects of ART                                                       
   None                                                   264               87.1
   Sometimes                                              29                9.6
   Always                                                 10                3.3
  Diagnosed with OIs in the past 6 months                                   
   None                                                   218               71.9
   Once and twice or more                                 85                28.1
  Recent CD4 level                                                          
   \<200                                                  7                 2.3
   200-499                                                147               48.5
   \>500                                                  149               49.2
  Chronic disease                                                           
   Yes                                                    80                26.4
   No                                                     223               73.6
  Screened for depression prior to ART                                      
   Yes                                                    77                25.4
   No                                                     226               74.6
  Stage of HIV/ADS                                                          
   T1                                                     290               95.7
   T2                                                     13                4.3
  Type of ART regimen                                                       
   1c                                                     81                26.7
   1d                                                     30                9.9
   1e                                                     155               51.2
   1f                                                     28                9.2
   2h                                                     9                 3.0
  Duration on HAART treatment (in months)                                   
   4-40                                                   41                13.5
   41-80                                                  104               34.3
   81-120                                                 128               42.2
   \>120                                                  30                9.9
  Duration from diagnosis HIV infection (in months)                         
   4-40                                                   37                12.2
   41-80                                                  103               34.0
   81-120                                                 125               41.3
   \>120                                                  38                12.5
  Receive food supplement from ARV treatment programmer                     
   Never                                                  228               75.2
   Previously                                             66                21.8
   Currently                                              9                 3.0
  Medication adherence                                                      
   Good adherence                                         164               54.1
   Poor adherence                                         139               45.9

###### 

Distributions of study participants by their stigma characteristics, Jimma University Medical Center, April-May 2018 (*N* = 303).

  Characteristics   Mean   Standard deviation   Item
  ----------------- ------ -------------------- ------
  Personal stigma   6.23   1.572                3
  Disclosure        7.49   1.819                3
  Public attitude   5.78   1.060                3
  Self-image        5.88   1.386                3

###### 

Bivariate binary logistic regression analysis and multivariable logistic regression analysis of the respondents in JUMC, April to May 2018.

  Characteristics           Depression   COR (95% CI) *p* value   AOR (95% CI) *p* value   
  ------------------------- ------------ ------------------------ ------------------------ -----------------------
  Sex                                                                                      
   Male                     107          37                       0.619 (0.377-1.015)∗     0.510 (0.264-0.986)∗∗
   Female                   102          57                       1                        1
  Marital status                                                                           
   Married                  97           28                       1                        1
   Single                   32           10                       0.310 (0.158-0.607)∗     0.889 (0.318-2.486)
   Divorced                 46           28                       0.336 (0.139-0.811)∗     1.638 (0.752-3.568)
   Separated                97           28                       0.654 (0.323-1.322)∗     0.778 (0.079-7.635)
   Widowed                  32           10                       0.215 (0.024-1.958)∗     3.610 (1.649-7.901)∗∗
  Occupation                                                                               
   Farmer                   12           6                        1                        1
   G. employee              74           26                       1.833 (0.367-9.166)      2.680 (0.443-16.220)
   Student                  9            3                        1.288 (0.333-4.982)      2.418 (0.517-11.303)
   Daily laborer            53           38                       1.222 (0.197-7.594)      1.395 (0.147-13.226)
   H. wife                  50           18                       2.629 (0.686-10.069)∗    3.757 (0.800-17.642)
   Unemployed               11           3                        1.320 (0.330-5.276)      1.232 (0.246-6.178)
  Alcohol use                                                                              
   Yes                      31           22                       1.754 (0.952-3.233)∗     1.590 (0.715-3.537)
   No                       178          72                       1                        1
  Khat use                                                                                 
   Yes                      49           29                       1.457 (0.847-2.505)∗     1.482 (0.717-3.063)
   No                       160          65                       1                        1
  Diagnosed with OIs                                                                       
   None                     166          52                       1                        1
   Once and twice or more   43           42                       0.321 (0.189-0.543)∗     3.122 (1.700-5.733)∗∗
  CD4 level                                                                                
   \<200                    5            2                        1                        1
   200-499                  93           54                       1.168 (0.218-6.274)      0.860 (0.119-6.192)
   \>500                    111          38                       1.696 (1.031-2.791)      1.096 (0.602-1.997)
  Medication adherence                                                                     
   Good adherence           105          59                       2.343 (1.475-3.723)∗     0.470 (0.266-0.831)∗∗
   Poor adherence           60           79                       1                        1
  Social support                                                                           
   Poor support             66           51                       1                        1
   Moderate support         110          33                       2.550 (1.150-5.654)∗     1.956 (0.785-4.871)
   Good support             33           10                       0.990 (0.442-2.220)      1.074 (0.428-2.697)

NB: ∗*p* \< 0.25, ∗∗*p* \< 0.05, 1 = reference.
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